Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
INFU InfuSystem	$9.64 +0.4%	$6.65	$4.61 ▼ $9.97	$196.91M	1.81	168,089 shs	246,343 shs
INGN Inogen	$7.53 +2.1%	$6.85	$5.70 ▼ $13.33	$203.77M	1.72	279,076 shs	116,129 shs
MDAI Spectral AI	$2.04	$2.42	$0.82 ▼ $3.25	$51.65M	0.9	532,243 shs	166,349 shs
NYXH Nyxoah	$6.39 +0.7%	$7.49	$5.55 ▼ $11.87	$217.75M	1.61	106,753 shs	68,183 shs

The Best Nuclear Energy Stocks to Buy

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
INFU InfuSystem	-0.21%	+3.00%	+74.23%	+65.52%	+39.13%
INGN Inogen	-1.60%	-4.29%	+17.17%	+9.19%	-41.27%
MDAI Spectral AI	-3.32%	-3.77%	-16.39%	+48.91%	+33.33%
NYXH Nyxoah	+1.12%	+0.48%	-20.15%	-23.80%	-23.80%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
INFU InfuSystem	3.403 of 5 stars	2.0	5.0	0.0	2.4	4.2	1.9
INGN Inogen	4.4838 of 5 stars	3.3	5.0	3.9	2.3	1.7	1.3
MDAI Spectral AI	3.1759 of 5 stars	3.5	4.0	0.0	2.6	3.3	0.0
NYXH Nyxoah	2.2453 of 5 stars	3.5	3.0	0.0	1.4	0.8	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
INFU InfuSystem	4.00	Strong Buy	$12.50	29.67% Upside
INGN Inogen	2.50	Moderate Buy	$11.00	46.18% Upside
MDAI Spectral AI	3.00	Buy	$3.50	71.57% Upside
NYXH Nyxoah	3.00	Buy	$15.00	134.63% Upside

Current Analyst Ratings Breakdown

Latest MDAI, NYXH, INGN, and INFU Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/22/2025	INFU InfuSystem	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$12.00
7/21/2025	INFU InfuSystem	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
6/16/2025	INGN Inogen	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$14.00
6/15/2025	INGN Inogen	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$14.00
5/22/2025	INGN Inogen	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Moderate Buy	$12.00

(Data available from 8/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
INFU InfuSystem	$139.89M	1.41	$0.75 per share	12.79	$2.47 per share	3.90
INGN Inogen	$343.47M	0.59	N/A	N/A	$7.38 per share	1.02
MDAI Spectral AI	$29.58M	1.75	N/A	N/A	($0.36) per share	-5.67
NYXH Nyxoah	$4.89M	44.53	N/A	N/A	$2.45 per share	2.61

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
INFU InfuSystem	$870K	$0.23	160.69	31.10	N/A	1.12%	2.78%	1.41%	N/A
INGN Inogen	-$35.89M	-$1.06	N/A	N/A	N/A	-7.58%	-13.77%	-8.52%	11/6/2025 (Estimated)
MDAI Spectral AI	-$15.31M	-$0.69	N/A	N/A	N/A	-51.97%	N/A	-8.69%	11/5/2025 (Estimated)
NYXH Nyxoah	-$64.10M	-$2.30	N/A	N/A	N/A	-1,541.84%	-79.18%	-54.92%	11/5/2025 (Estimated)

Latest MDAI, NYXH, INGN, and INFU Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/18/2025	Q2 2025	NYXH Nyxoah	-$0.62	-$0.63	-$0.01	-$0.63	$1.33 million	$1.58 million
8/12/2025	Q2 2025	MDAI Spectral AI	-$0.07	-$0.10	-$0.03	-$0.31	$5.44 million	$5.07 million
8/7/2025	Q2 2025	INGN Inogen	-$0.22	-$0.15	+$0.07	-$0.15	$90.40 million	$92.28 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
INFU InfuSystem	N/A	N/A	N/A	N/A	N/A
INGN Inogen	N/A	N/A	N/A	N/A	N/A
MDAI Spectral AI	N/A	N/A	N/A	N/A	N/A
NYXH Nyxoah	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
INFU InfuSystem	0.50	1.98	1.59
INGN Inogen	N/A	3.03	2.67
MDAI Spectral AI	N/A	0.87	0.84
NYXH Nyxoah	0.29	2.63	3.35

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
INFU InfuSystem	71.13%
INGN Inogen	89.94%
MDAI Spectral AI	67.08%
NYXH Nyxoah	N/A

Insider Ownership

Company	Insider Ownership
INFU InfuSystem	10.20%
INGN Inogen	1.46%
MDAI Spectral AI	30.70%
NYXH Nyxoah	17.11%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
INFU InfuSystem	410	20.43 million	19.10 million	Optionable
INGN Inogen	1,030	27.04 million	26.65 million	Optionable
MDAI Spectral AI	83	25.32 million	17.55 million	Not Optionable
NYXH Nyxoah	110	34.06 million	28.23 million	Not Optionable

MDAI, NYXH, INGN, and INFU Headlines

Recent News About These Companies

Nyxoah: High-Risk High-Reward Medtech To Own

August 20 at 6:22 PM | seekingalpha.com

Nyxoah (NASDAQ:NYXH) Posts Quarterly Earnings Results

August 20 at 4:54 PM | marketbeat.com

Nyxoah S.A. (NASDAQ:NYXH) Q2 2025 Earnings Call Transcript

August 20 at 8:50 AM | insidermonkey.com

Nyxoah (NASDAQ:NYXH) Stock Price Down 4.6% on Disappointing Earnings

August 20 at 2:36 AM | americanbankingnews.com

Nyxoah reports Q2 EPS (EUR 0.55) vs. (EUR 0.43) last year

August 19 at 6:41 AM | msn.com

Q2 2025 Nyxoah SA Earnings Call Transcript

August 18 at 12:10 AM | gurufocus.com

Nyxoah SA (NYXH) Q2 2025 Earnings Call Transcript

August 18 at 7:32 PM | seekingalpha.com

Nyxoah Launches Genio System in U.S. Following FDA Approval

August 18 at 5:51 PM | tipranks.com

Nyxoah Reports Second Quarter Financial and Operating Results

August 18 at 4:10 PM | globenewswire.com

Uncovering Potential: Nyxoah's Earnings Preview

August 15, 2025 | benzinga.com

Nyxoah SA (NYXH) Q2 2025: Everything You Need To Know Ahead Of Earnings

August 15, 2025 | finance.yahoo.com

Nyxoah Secures FDA Clearance for Genio System to Treat Sleep Apnea

August 15, 2025 | zacks.com

Nyxoah stock surges after FDA approves Genio system for sleep apnea

August 11, 2025 | investing.com

Nyxoah Shares Climb Following FDA Clearance of Genio Device for Sleep Apnea Treatment

August 11, 2025 | msn.com

Nyxoah Announces Preliminary Results for the Second Quarter of 2025

August 11, 2025 | globenewswire.com

Nyxoah wins FDA nod for sleep apnea neuromod system

August 9, 2025 | massdevice.com

Nyxoah Receives Approval from FDA for Genio® System for the Treatment of Obstructive Sleep Apnea

August 8, 2025 | globenewswire.com

Nyxoah (NYXH) Expected to Announce Earnings on Tuesday

July 30, 2025 | marketbeat.com

Nyxoah stock rises on positive DREAM study data publication

July 29, 2025 | investing.com

Nyxoah to Release Second Quarter 2025 Financial Results on August 18, 2025

July 29, 2025 | globenewswire.com

Nyxoah’s DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine

July 29, 2025 | uk.finance.yahoo.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

MDAI, NYXH, INGN, and INFU Company Descriptions

InfuSystem NYSE:INFU

$9.64 +0.04 (+0.42%)

Closing price 03:59 PM Eastern

Extended Trading

$9.62 -0.03 (-0.26%)

As of 04:04 PM Eastern

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.

Inogen NASDAQ:INGN

$7.52 +0.16 (+2.10%)

Closing price 03:59 PM Eastern

Extended Trading

$7.53 +0.00 (+0.07%)

As of 04:04 PM Eastern

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.

Spectral AI NASDAQ:MDAI

$2.04 0.00 (0.00%)

Closing price 03:59 PM Eastern

Extended Trading

$2.04 0.00 (-0.25%)

As of 04:04 PM Eastern

Spectral AI, Inc., an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView System, a predictive analytics platform integrated with the predictive AI-Burn, which combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential and offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention; and DeepView SnapShot M, a handheld, portable, and wireless diagnostic tool, that provides a potential enhanced and expanded use for the government and emergency care, first responders, and potentially home health care professionals. The company is headquartered in Dallas, Texas.

Nyxoah NASDAQ:NYXH

$6.39 +0.04 (+0.68%)

Closing price 03:59 PM Eastern

Extended Trading

$6.35 -0.04 (-0.67%)

As of 04:04 PM Eastern

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time